Moderna stock was on track to see a weekly gain of 10% as of Wednesday following the first reported bird flu death in the US.
The FDA has required the manufacturers of the RSV Vaccines Abrysvo and Arexvy to add a new warning to their labels about the ...
Berenberg Bank analyst Kerry Holford maintained a Hold rating on FRESNILLO (FNLPF – Research Report) yesterday and set a price target of ...
Pfizer has been awarded breakthrough status ... The news comes just days after GlaxoSmithKline called a halt to enrolment and vaccination in three trials of its RSV shot in pregnant women while ...
GlaxoSmithKline has found a replacement for head of vaccines R&D Emmanuel Hanon, who left the company for a US biotech earlier this year, hiring Phil Dormitzer from ...
The FDA has mandated updated safety labeling for two respiratory syncytial virus vaccines, Pfizer's Abrysvo and GlaxoSmithKline's Arexvy, following the identification of an increased risk of ...
Moderna stock was on track to see a weekly gain of over 20% as of Wednesday following the first reported bird flu death in the US.
Hosted on MSN3d
Is there a vaccine for H5N1? What we know as first person with severe case of bird flu died in United StatesThe H5N1 bird flu has been reported to have caused the death of a patient in Louisiana. Such a case poses a significant ...
Ramos, previously Pfizer's senior vice president and global head of BioTherapeutics R&D, has been appointed to the board of ...
The global pediatric vaccine market is set for unprecedented growth, with a valuation of US$ 54,130.1 million in 2023, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback